Clinical observation of compound xiatianwu tablets in treatment of 120 cases with active rheumatoid arthritis.
- Author:
Shou-Yuan YU
1
;
Zhao-An YU
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Arthritis, Rheumatoid; drug therapy; immunology; metabolism; pathology; C-Reactive Protein; metabolism; Drugs, Chinese Herbal; pharmacology; therapeutic use; Erythrocytes; drug effects; Female; Humans; Immunoglobulins; metabolism; Male; Middle Aged; Tablets; Treatment Outcome; Young Adult
- From: China Journal of Chinese Materia Medica 2013;38(6):899-901
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the clinical efficacy of Compound Xiatianwu tablets in the treatment of active rheumatoid arthritis.
METHODOne hundred and eighty cases with active rheumatoid arthritis were randomly divided into the control group (60 cases) with leflunomide, sulfasalazine, and celecoxib; the treatment group (120 cases) given compound Xiatianwu tablets on the basis of the control group, 2 tablets each time, 3 times/day, with the course of treatment of 3 month. Patients of the two groups were observed for clinical symptoms, erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, and immunoglobulin changes before and after the treatment.
RESULTThe treatment group showed an overall efficiency of 94. 2% , the Xiatianwu group showed an overall efficiency of 80. 0%, while the control group showed an overall efficiency of 81.7%. The difference among the three groups was statistically significant (P <0. 05 or P <0. 01) , indicating that the treatment group was superior to the Xiatianwu group, while the Xiatianwu group was superior to the control group.
CONCLUSIONCompound Xiatianwu tablets has remarkable effect in the treatment of active rheumatoid arthritis.
